To view this email as a web page, click here.
April 30, 2019
 
Promising New Option for Treatment for Tardive Dyskinesia
The results of a phase 3 trial demonstrated significant benefit over placebo.
Image: ©Shutterstock
Read more
 
Tardive Dyskinesia: A Review of the Literature
Download this educational supplement to briefly review key recent and seminal articles.
Image: Tardive Supplement Cover
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.